CVIJIC CHRISTINE MIKAIL (President and CFO) sold 5.1% of their position (4.80K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $166.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/2/2026ACC: 0001543663-26-000015
Officer· President and CFO
Since Feb 2026
-4.80K
Net shares
Net seller
$166.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.80K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−739.00
Price / share
$34.06
Trade value
$25.17K
% of position
0.8%
7/1/2026
93.64K→92.90K
Common Stock
Direct
Shares
−2.53K
Price / share
$34.58
Trade value
$87.52K
% of position
2.7%
7/2/2026
92.90K→90.37K
Common Stock
Direct
Shares
−1.53K
Price / share
$35.23
Trade value
$53.90K
% of position
1.7%
7/2/2026
90.37K→88.84K
Total
Net shares
−4.80K
Net value
-$166.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −739.00 | $34.06 | $25.17K | 0.8% | 93.64K | 92.90K |
| Common Stock Direct | 7/2/2026 | S · Sale | −2.53K | $34.58 | $87.52K | 2.7% | 92.90K | 90.37K |
| Common Stock Direct | 7/2/2026 | S · Sale | −1.53K | $35.23 | $53.90K | 1.7% | 90.37K | 88.84K |
| Total | −4.80K | -$166.59K | ||||||
Derivative Transactions0
No derivative transactions reported